Introduction and hypothesis The objective was to compare midurethral sling (MUS) urinary outcomes in women with stress urinary incontinence (SUI) only versus mixed UI (MUI). Methods This was a retrospective cohort study of women who underwent primary MUS surgery for SUI. MUI was defined as at least "moderately" bothersome urgency and stress incontinence on the Urinary Distress Inventory (UDI-6) subscale of the Pelvic Floor Distress Inventory-20 (PFDI-20). The primary outcome was SUI cure defined by a response of "no," "not at all," or "somewhat" bothersome SUI on both of the two UDI-6 stress subscale items. Symptom impact was assessed using the Urinary Impact Questionnaire (UIQ-7). Multivariable models assessed the effect of MUI on SUI outcomes. Results One thousand one hundred and ninety-one primary MUS procedures were reviewed. Seven hundred and fifteen out of 1,191 (60 %) questionnaires were returned and 534 out of 715 (75 %) had completed baseline and follow-up questionnaires. Mean (±SD) follow-up time was 35±15 months.
Introduction
Fifty percent of US women with urinary incontinence have mixed urinary incontinence (MUI) symptoms [1] . However, research into women with MUI is problematic because there is no commonly accepted definition of this condition. The International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology report defines MUI as "the complaint of involuntary leakage associated with urgency and also with exertion, effort, sneezing, or coughing" [2] . Attempts to identify objective definitions of MUI that are clinically significant and reproducible have been unsuccessful [3, 4] . Many women with MUI will undergo midurethral sling (MUS) procedures primarily for treatment of the stress incontinence component of their incontinence; however, outcomes of sling procedures in the MUI population are not well understood.
While it was once thought that women with mixed incontinence may be poor candidates for sling procedures because of the potential for the worsening of overactive bladder symptoms (OAB), more recent trials suggest that over 50 % of women with MUI undergoing MUS procedures might experience improvement of their OAB symptoms [5] [6] [7] . However, women with MUI have had higher stress incontinence failure rates compared with women with SUI alone in secondary analyses of clinical trials [7] . These trials are limited in their applicability because they included only women with "stresspredominant" MUI, which has various definitions [6] [7] [8] [9] .
Our primary aim was to compare stress incontinence success rates after MUS procedures in women with MUI versus women with stress incontinence only in a tertiary care, academic, female pelvic medicine and reconstructive surgery practice. We hypothesized that women with MUI might have lower stress incontinence success rates than women with stress incontinence only. We also aimed to compare overall lower urinary tract symptom outcomes, symptom-specific impact on quality of life outcomes, patient satisfaction, and an impression of improvement between women with MUI and women with stress incontinence only.
Materials and methods
All women who underwent midurethral sling procedures from 1 April 2006 to 31 December 2009 by the Division of Urogynecology and Pelvic Reconstructive Surgery at the University of Alabama at Birmingham (UAB) were included in this retrospective cohort study. Midurethral sling procedures were identified by CPT code. The Institutional Review Board approved all data collection, and the study was exempted by the Carilion Clinic Institutional Review Board.
Preoperative clinical and demographic information, including urodynamic parameters, and preoperative symptom distress and impact questionnaires, were abstracted from the clinic charts. The exposure was MUI, which was defined as patient-reported SUI and UUI. SUI was defined as patient reports of at least moderate bother for both SUI questions on the UDI-6. UUI was defined as patient reports of at least moderate bother in answer to item #16 of the Pelvic Floor Distress Inventory, "Do you usually experience urine leakage associated with a feeling of urgency, that is, a strong sensation of needing to go to the bathroom?" Women in the SUI group responded "no" to UUI item #16, or "yes" with symptoms either "not at all" or "slightly" bothersome. All participants had a positive stress test to confirm SUI. The minimum follow-up time was 12 months. All eligible patients were mailed questionnaires including measures of satisfaction and patient impression of improvement. All data were collected by mail; no questions were assessed by telephone. All women were undergoing a primary midurethral sling procedure.
Midurethral sling types included the retropubic and transobturator approaches. The retropubic sling used was tension-free vaginal tape (TVT; Gynecare, Somerville, NJ, USA). The transobturator sling (TOT) used was the Monarc (American Medical System, Minnetonka, MN, USA). All slings were performed as described [10] . Procedures were performed by four attending physicians, who were overseeing resident and fellow physicians during the study period. Surgeons were not involved in extracting or entering any data for this study.
The primary outcome of stress incontinence "cure" was improvement in SUI symptoms from baseline, which was defined as a response of either "no" SUI, or "yes" and "not at all" or "somewhat" bothersome SUI to both questions of the UDI-6 stress subscale: "Do you usually experience small amounts of urine leakage (that is, drops)?" and "Do you usually experience urine leakage related to coughing, sneezing, or laughing?" [11] . Stress urinary incontinence symptoms were also assessed using the Medical Epidemiologic and Social Aspects of Aging (MESA) questionnaire stress subset scores, ranging from 0 to 27 where higher scores represent worse stress incontinence. Urgency urinary incontinence (UUI) symptoms were also measured by using the MESA urge subscale score, which ranges from 0 to 18 where higher scores represent worse UI [12] . Overall urinary symptom distress was measured using the UDI-6, which is scored from 0 to 100, with higher scores reflecting greater symptom distress [11, 13] .
Symptom-specific impact on quality of life (QOL) was assessed using the Incontinence Impact Questionnaire (IIQ-7) [11, 13] . The IIQ-7 consists of seven questions and is scored from 0 to 100, where a higher score represents a greater impact on QOL.
Patient satisfaction and patient impression of improvement were assessed using the Patient Satisfaction Questionnaire (PSQ), and Patient Global Impression of Improvement Questionnaire (PGI-I) respectively [14, 15] . The PSQ consists of a single item, "How satisfied are you with your progress since your surgery?" where the three possible responses are "completely satisfied," "somewhat satisfied," and "not satisfied." The PGI-I consists of a single item, "Circle the one response that best describes how your urinary tract condition is now, compared with how it was before you had surgery." There are seven possible responses ranging from "very much better" to "very much worse." Symptoms of pelvic organ prolapse were assessed using the Pelvic Organ Prolapse Distress Inventory (POPDI-6) [16] .
All questionnaires were collected preoperatively and again at follow-up and were scored using published protocols. Continuous variables were evaluated using Student's t test and Wilcoxon rank-sum test where appropriate. The Chi-squared test of association and Fisher's exact test were used on categorical variables. Logistic regression was used to perform multivariable analysis controlling for age as a continuous variable, baseline MESA stress score, diabetes, and baseline POPDI-6 as a continuous variable. A p value of <0.05 was considered statistically significant. Statistical analyses were conducted using SAS version 9.1 (SAS Institute, Cary, NC, USA).
Results
A total of 1,191 primary MUS procedures were performed during the study period. Questionnaires were mailed to all 1,191 patients and 715 out of 1,191 (60 %) responded. Complete baseline and follow-up measures were available for 534 out of 1,191 (45 %). Mean time from surgery until the date on which the questionnaire was completed was 34.7 ± 14.5 months, with a range of 11.4-66.5 months. Women with MUI had a longer time from surgery (35. Table 1 . Women with MUI were older, had a higher number of prescription medications, in addition to a higher prevalence of diabetes, and they had had a prior hysterectomy (all p<0.05).
Women with MUI reported worse baseline overall incontinence according to the UDI-6 score, and worse baseline stress incontinence according to the MESA stress subset, higher MESA urge scores, and a higher impact on QOL according to IIQ-7 compared with the SUI cohort. There was no difference in the prevalence of urodynamic SUI or abdominal leak point pressures between groups (Table 1) . Eligible questionnaire nonresponders (those who had completed baseline UUI questions) were younger, more overweight, and less likely to have undergone other prolapse surgery ( Table 2) .
Stress continence cure rates were 64 % (184 out of 289; 95 % CI 58.0, 69.0) in the MUI group and 84.5 % (207 out of (Table 3) . According to the PGI-I, women with MUI were less likely to describe their improvement as "much better" or "very much better" than women with SUI only (58.1 vs 74 %; p=0.0001), and according to the PSQ, women with MUI were less likely to report being "somewhat" or "completely" satisfied (78 vs 88.4 %; p=0.002; Table 3 ). In the multivariable model, women with MUI were at an increased risk of SUI failure (OR 2.5, 95 % CI 1.6-4.0), adjusting for baseline SUI symptoms, age, diabetes, hysterectomy, and baseline Pelvic Organ Prolapse Distress Inventory (POPDI-6) symptoms, and time to follow-up.
Discussion
Women with MUI had lower stress incontinence surgical success rates compared with women with SUI only (64 vs 84.5 % respectively) after midurethral sling placement. This risk of failure remains, even when controlling for worse baseline stress symptoms and other potential confounders (OR 2.5). Also, women with MUI reported less global improvement and satisfaction based on PGI-I and PSQ results. However, women with MUI experienced similar, if not greater, improvements in overall lower urinary tract symptoms, similar improvements in symptom-specific impact on quality of life, and similar improvements in stress incontinence. Our finding of an increased risk of failure in women with MUI is similar to a prior report, which was a secondary analysis of a clinical trial comparing retropubic with transobturator MUS procedures [10] . They found that an increase in the MESA urge score by 10 points was predictive of stress incontinence failure (OR 1.97, 95 % CI 1.21-3.21). The OR of 2.5 that we report is higher, but this may be accounted for by their inclusion criteria of "stress-predominant" urinary incontinence.
Lower success rates were seen in the MUI group (64 vs 84.5 %), even when controlling for other known factors that would impact on SUI treatment outcomes, including baseline SUI symptom score. Therefore, we are not able to identify the factor that contributes to this lower success rate in the MUI group. Some have argued for, and some against, there being a common process in stress and urgency incontinence in women with MUI. Specifically, it has been proposed that proximal urethral funneling in women with SUI may cause detrusor overactivity [17] . The urethra plays a significant role in the pathophysiology of SUI and UUI, warranting research efforts characterizing the neurophysiological function of the urethra in these patient cohorts. Our cure rate is similar to a prior case-control study that reported 64 % cure rates in women with MUI, and 86 % in women with SUI [18] . Another case-control study of 137 women with MUI showed a higher overall cure rate of 85-95 % [19] . This may be explained by the higher baseline UDI-6 scores in our sample, indicating worse baseline symptoms.
Improvement in overall urinary tract symptoms was similar in the two groups. The difference in overall improvement between the groups according to the UDI-6 (−16.1, Table 3 ) approaches some estimates of the minimum important difference (MID) for the UDI-6. The MID for the UDI-6 has been reported to be −22 to −6 in a population of women with SUI, or predominantly SUI [20] . The MID for the UDI-6 is higher in women with UUI (−35 to −45) [21] . Our sample more closely aligns with the stress incontinence, or stresspredominant population, as is reflected in the baseline MESA subscale scores for SUI and UUI (Table 1) .
Despite similar overall improvements in overall urinary tract symptoms, women with MUI were not as satisfied as the SUI group. This finding supports our choice of definition of treatment success, and indicates that SUI improvement rates are a stronger driving force behind patient satisfaction and perception of improvement in women undergoing midurethral slings. It is likely that respondents in this study were thinking more specifically about their stress incontinence outcome, and not taking into account their overall greater improvement in lower urinary tract symptoms, when reporting their satisfaction.
The strengths of this study include a relatively large sample size and high response rate for this study design. Further, the study is strengthened by an appropriate design for the question being asked. These data are also important and have good external validity because our sample includes all women undergoing MUS procedures in a tertiary care center carried out by FPMRS surgeons, and is not limited to women with SUI alone or "stress-predominant" MUI. This study is limited by a possible nonrespondent bias, missing data amongst some respondents, and by the nonresponders being slightly more obese and having had more prior surgery for prolapse. We also do not have information on whether participants received additional incontinence treatments after the index surgery. Finally, we have two sling types represented in our sample. Two prior reports have demonstrated no difference in cure rates between retropubic and transobturator slings [8, 21, 22] .
Women with MUI symptoms as defined, had lower stress incontinence success rates after MUS than women with SUI alone. However, despite lower satisfaction rates with the MUS procedure, women with MUI experience a greater overall improvement in lower urinary tract symptoms, and similar improvements in SUI symptoms. Women with MUI should be counseled extensively prior to MUS procedures regarding SUI and UUI outcomes. Future studies regarding potential combined pathophysiological factors for SUI and UUI may lead to identification of the driving force behind lower SUI success rates in women with MUI who undergo MUS procedures. Women with MUI symptoms may also benefit from perioperative behavioral and/or medication therapy and this needs to be tested with a randomized trial.
